Stem Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $148M+2.4% YoYTTM through 30 Jun 2026
Net Income -$73.1MTTM through 30 Jun 2026
Free Cash Flow $298KTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 38.4% |
| EBITDA Margin | 1.0% |
| Operating Margin | -35.6% |
| Net Margin | -49.4% |
Returns
-55.3%ROE
44.6%ROA
Balance Sheet Health
Debt / Equity-1.43x
Current Ratio0.91x
Net Debt$306.9M
Cash & Equivalents$38.4M
Quality Metrics
Altman Z-Score-7.63
Piotroski F-Score5 / 9
FCF Margin0.2%
Rule of 407.0
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $156.3M
Diluted EPS-$8.42TTMFY2022: $-16.17
Dividend
No dividend
Capital Allocation
R&D Spend$27M
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Software, services, and edge hardware | $141.4M | +24.9% | View detailsThe company is prioritizing this segment as part of its software-centric strategy to drive higher margins and recurring revenue. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.